IVD LATAM Insight Report 2024

The in-vitro diagnostics (IVD) market in Latin America is entering a period of rapid transformation. Healthcare reforms, cost pressures, and private sector expansion are reshaping how diagnostics are accessed, delivered, and purchased across the region. Clearstate’s LATAM IVD Market Insight Report 2024 provides an in-depth look at the trends, opportunities, and market forces defining the region’s next growth chapter — giving MedTech leaders the data and direction they need to compete effectively.

Download

scientist-testing-chemical-medical-research-digital-remix

Market Outlook & Forecasts

LATAM diagnostics market to exceed USD 4.6B by 2029, with molecular and tissue diagnostics leading growth.

Systemic Reforms & Policy Shifts

Colombia’s ADRES and Mexico’s IMSS-BIENESTAR are reshaping procurement, coverage, and test demand.

Infrastructure & Readiness

Automation advances in Brazil and Chile, while smaller markets rely on manual workflows, creating scalable platform opportunities.

Competitive Landscape

Chinese and regional players are rising, with multinationals adjusting strategies to defend and expand local share.

Strategic Outlook

Public reforms and private investment drive dual-engine growth, guiding tactical market entry, positioning, and channel alignment.